Evidence map›Paper›PMID 40732259›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

A High-Throughput Behavioral Assay for Screening Novel Anxiolytics in Larval Zebrafish.

Alice Dang, Gina Zhao, Jiale Xu, Mahendra Wagle, Su Guo

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alice DangDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143-2811, USA.
Gina ZhaoDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143-2811, USA.
Jiale XuDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143-2811, USA.
Mahendra WagleDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143-2811, USA.
Su GuoDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143-2811, USA.ORCID 0000-0002-7342-0108

Funding

Role of endocannabinoid signaling in a preference/aversion circuitryR01DA053385 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Su Guo · 2022 to 2026
$2.5M
NIDA NIH HHS R01 DA053385NIH HHS NIH DA 053385
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anxietyanxiolyticsbehavioral assayhigh-throughput screeningstrong dark avoidancezebrafish

Identifiers

PMID40732259
PMCPMC12299768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.